Pharmabiz1h
EMA committee recommends approval for CStone Pharma’s Cejemly in combo with chemotherapy as first-line treatment for NSCLC
CStone Pharmaceuticals, an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, announced that the Committee for Medicinal Products for Human ...
Pharmabiz1h
Aurigene opens biologics facility in Genome Valley for process development and clinical scale manufacturing capabilities
Aurigene Pharmaceutical Services, a Dr Reddy’s Laboratories company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad. The facility ...
Pharmabiz2h
Bio-Thera Solutions gets positive CHMP opinion for Avzivi, a biosimilar referencing Avastin
Bio-Thera Solutions Inc., a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, announced that the Committee for Medicinal Products for Human Use ...
Pharmabiz3h
Dizal’s pivotal WU-KONG1B study of sunvozertinib in relapsed or refractory NSCLC with EGFR exon 20 insertion mutations meets primary endpoint
Dizal, a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, presented the latest data from the inaugural global pivotal study ...
Pharmabiz4h
Organon India appoints Vivek Soares as its new country lead for India and South Asia
Organon India announces the appointment of Vivek Soares as its new country lead for India and South Asia, commencing on June 1, 2024. Soares will take the reins from Anjan Sen, who will retire after ...
Pharmabiz4h
Immunocan introduces innovative alpaca-derived nanobody discovery platform, ImmuAlpaca mouse
Immunocan introduces innovative alpaca-derived nanobody discovery platform, ImmuAlpaca mouse: Boston Tuesday, June 4, 2024, 17:00 Hrs [IST] Immunocan, a company specializes in usi ...
Pharmabiz6h
EMA committee recommends approval of AstraZeneca’s Tagrisso with the addition of chemotherapy for patients with EGFR-mutated advanced lung cancer
EMA committee recommends approval of AstraZeneca’s Tagrisso with the addition of chemotherapy for patients with EGFR-mutated advanced lung cancer ...
Pharmabiz8h
Philogen, Sun Pharma seek European marketing approval for Nidlegy to treat neoadjuvant locally advanced fully resectable melanoma
Our Bureau, Mumbai Tuesday, June 4, 2024, 13:45 Hrs [IST] ...
Pharmabiz8h
Gujarat FDCA cancels licenses of 276 retailers & suspends licenses of 119 retailers for violation of norms
In a massive crackdown on the illegal and clandestine supply chain of narcotic drugs and spurious drugs in the state, the Gujarat Food and Drug Control Administration (FDCA) has suspended licenses of ...
Pharmabiz8h
Despite challenges, CAM therapies hold immense promise for enhancing healthcare outcomes: Expert
Despite challenges including lack of standardization and regulation across various Complementary and Alternative Medicine (CAM) therapies, the ongoing advancement and integration of CAM therapies hold ...
Pharmabiz11h
Bayer collaborates with Samsung to address data gaps on sleep disturbances associated with menopause
Bayer collaborates with Samsung to address data gaps on sleep disturbances associated with menopause: Berlin Tuesday, June 4, 2024, 10:00 Hrs [IST] Bayer AG announced a strategic ...
Pharmabiz12h
BD to buy Edwards Lifesciences' Critical Care product group for $4.2 billion
BD to buy Edwards Lifesciences' Critical Care product group for $4.2 billion: Franklin Lakes, New Jersey Tuesday, June 4, 2024, 09:00 Hrs [IST] BD (Becton, Dickinson and Company), ...